M. J. Biopharm Private Limited Ethambutol Export Data — India (DGFT 2022–2026)

Name: M. J. Biopharm Private Limited Ethambutol Export Records India — #12 Exporter, 6 Shipments, $171.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ethambutol

India Pharmaceutical Trade Intelligence

$1.1B97 Suppliers133 CountriesHS 30049057

ExportsIndia → CONGO DR46.8%India → NIGERIA21.9%

ImportsBULGARIA → India$2.5K UNITED KINGDOM → India$1.7K

#1 Supplier: LUPIN LIMITED #1 Buyer: CAMESKIN/CORDAID

M. J. Biopharm Private Limited — Ethambutol Exporter #12 | $171.1K Trade Value | TransData Nexus | TransData Nexus

M. J. Biopharm Private Limited — Ethambutol Exporter Profile

Indian Pharmaceutical Exporter · #12 for Ethambutol · $171.1K export value · DGFT Verified

M. J. Biopharm Private Limited is the #12 Indian exporter of Ethambutol with $171.1K in export value and 6 verified shipments. M. J. Biopharm Private Limited holds a 0.0% market share in Ethambutol exports across 1 countries. The company exports 6 pharmaceutical products worth $22.4M across 4 therapeutic categories.

M. J. Biopharm Private Limited — Ethambutol Export Profile: Buyers & Destinations

M. J. Biopharm Private Limited Ethambutol export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Ethambutol?

Country	Value	Shipments	Share
NETHERLANDS	$5.0M	100	21.6%
SOUTH AFRICA	$4.8M	95	20.5%
NIGERIA	$2.9M	57	12.3%
PHILIPPINES	$2.5M	51

Who Are the Top Buyers of Ethambutol from India?

Buyer	Country	Value	Orders
NATIONAL TUBERCULOSIS AND LEPROSY	NIGERIA	$1.9M	39
I+SOLUTIONS	NETHERLANDS	$1.2M	24
SEKRETARIAT DITJEN PENCEGAHAN DAN P	INDONESIA	$900.0K	18
MINISTRY OF HEALTH OF THE REPUBLIC	ZAMBIA	$650.0K	13
GDF TILBURG SRS D102TC	NETHERLANDS	$550.0K	11
CAMESKIN/CORDAID	CONGO DR	$450.0K	9
LA PHARMACIE CENTRALE DE TUNISIE	TUNISIA	$150.0K	3
THE NATIONAL LUNG HOSPITAL	VIETNAM	$100.0K	2
NATIONAL PROGRAMME FOR TB	SRI LANKA	$100.0K	2
NATIONAL DRUG SERVICE ORGANISATION	LESOTHO	$100.0K	2

India's Ethambutol is purchased by 458 buyers worldwide. The top buyer is NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA), followed by I+SOLUTIONS and SEKRETARIAT DITJEN PENCEGAHAN DAN P.

How Does M. J. Biopharm Private Limited Compare to Nearest Ethambutol Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
10	OMNICALS PHARMA PRIVATE LIMITED	$264.3K	10	6	$26.4K
11	VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED	$211.2K	11	1	$19.2K
12	M. J. BIOPHARM PRIVATE LIMITED ★	$171.1K	6	1	$28.5K
13	PHAR & VIDE	$147.9K	7	2	$21.1K
14	AVALOR HEALTH CARE PRIVATE LIMITED	$113.6K	6	1	$18.9K

M. J. Biopharm Private Limited ranks #12 among 97 Indian Ethambutol exporters. Average shipment value of $28.5K compared to the market average of $522.7K. The closest competitors by value are OMNICALS PHARMA PRIVATE LIMITED and VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED.

Which Indian Ports Ship Ethambutol Exports?

Port	Shipments	% Share
SAHAR AIR	305	21.6%
SAHAR AIR CARGO ACC (INBOM4)	246	17.4%
DELHI AIR CARGO ACC (INDEL4)	121	8.6%
DELHI AIR	113	8.0%
NHAVA SHEVA SEA (INNSA1)	94	6.7%
Bombay Air	80	5.7%
JNPT	67	4.8%
JNPT/ NHAVA SHEVA SEA	63	4.5%

Geopolitical & Trade Policy Impact on M. J. Biopharm Private Limited's Ethambutol Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like M. J. Biopharm. Escalating tensions in the Middle East, particularly the Israel-Iran conflict, have disrupted key shipping routes through the Red Sea and the Suez Canal. Major carriers have suspended or rerouted shipments, leading to increased transit times and freight costs. This situation poses significant logistical hurdles for time-sensitive pharmaceutical exports. (livemint.com)

Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the U.S. has also implemented policies favoring domestic manufacturing, such as the "Buy American" initiative, which could impact Indian companies' access to this lucrative market. (walterhealthcare.co.in)

In the European Union, stringent regulations like the Falsified Medicines Directive necessitate rigorous compliance from exporters. Indian companies must navigate these complex requirements to maintain market access, emphasizing the need for robust quality assurance systems. (ipa-india.org)

M. J. Biopharm Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent guidelines to ensure product safety and efficacy. Indian companies have faced challenges, including increased compliance costs and potential reductions in export volumes due to evolving regulations. (transdatanexus.com)

For M. J. Biopharm, maintaining adherence to these standards is crucial to sustain and expand its export markets. Investments in quality control, staff training, and infrastructure are essential to meet the evolving requirements and to build trust with international partners and regulatory bodies.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ethambutol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: M. J. Biopharm Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 133+ countries, 458+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ethambutol

Ethambutol

M. J. Biopharm Private Limited — Ethambutol Exporter Profile

M. J. Biopharm Private Limited — Ethambutol Export Profile: Buyers & Destinations

Where Does India Export Ethambutol?

Who Are the Top Buyers of Ethambutol from India?

What Is India's Total Ethambutol Export Value and How Much Does M. J. Biopharm Private Limited Contribute?

What Is the Average Shipment Value for M. J. Biopharm Private Limited's Ethambutol Exports?

How Does M. J. Biopharm Private Limited Compare to Other Indian Ethambutol Exporters?

Regulatory Requirements: Exporting Ethambutol to Key Markets

South Africa — SAHPRA

Nigeria — NAFDAC

How Does M. J. Biopharm Private Limited Compare to Nearest Ethambutol Exporters?

Which Indian Ports Ship Ethambutol Exports?

What Other Tuberculosis Medications Products Does M. J. Biopharm Private Limited Export?

Geopolitical & Trade Policy Impact on M. J. Biopharm Private Limited's Ethambutol Exports

M. J. Biopharm Private Limited — Regulatory Compliance & Quality Standards

About M. J. Biopharm Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ethambutol Export Data from M. J. Biopharm Private Limited

Ethambutol Stats

Company Overview

Top Products by M. J. Biopharm Private Limited

Related Analysis

Need Detailed Export Data?

Data Source